CLINICAL_TRIALS
trial_result
· 2025-01-08
Clinical Trial Update: A GBT021601 ADME Microtracer Study in Healthy Volunteers [Phase 1]
Summary
Pfizer completed a Phase 1 ADME microtracer study of GBT021601 in healthy volunteers; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Sickle Cell Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-01-08